Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Not Yet Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0111033 (Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04007744Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsTreatment